MARKET

CDXS

CDXS

Codexis Inc
NASDAQ
1.300
+0.020
+1.56%
After Hours: 1.300 0 0.00% 19:30 10/26 EDT
OPEN
1.300
PREV CLOSE
1.280
HIGH
1.300
LOW
1.280
VOLUME
392.38K
TURNOVER
--
52 WEEK HIGH
2.980
52 WEEK LOW
0.9583
MARKET CAP
142.36M
P/E (TTM)
-3.8371
1D
5D
1M
3M
1Y
5Y
1D
Piper Sandler Sticks to Their Buy Rating for Codexis (CDXS)
TipRanks · 5d ago
Weekly Report: what happened at CDXS last week (1012-1016)?
Weekly Report · 10/19 10:21
Weekly Report: what happened at CDXS last week (1005-1009)?
Weekly Report · 10/12 10:26
Weekly Report: what happened at CDXS last week (0928-1002)?
Weekly Report · 10/05 10:26
Weekly Buzz: EW, ABBV, MIRM Score FDA Wins, AZN, NVO Strike Deals; LLY, KOD Report Data
NASDAQ · 10/02 16:13
Codexis partners with siRNA drug innovator for enzymatic oligonucleotide synthesis
Seeking Alpha · 09/28 11:02
Codexis Shares Gain on Agreement With Undisclosed Drug Innovator
Dow Jones · 09/28 11:00
Weekly Report: what happened at CDXS last week (0921-0925)?
Weekly Report · 09/28 10:21
More
About CDXS
Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.

Webull offers Codexis Inc stock information, including NASDAQ: CDXS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDXS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDXS stock methods without spending real money on the virtual paper trading platform.